We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NICXF market cap is 22.13M. The company's latest EPS is EUR -0.5519 and P/E is -0.62.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 4.93M | 7.83M | 13.99M | 8.08M | 4.03M |
| Operating Income | -21.24M | -18.26M | -6.68M | -45.81M | -34.06M |
| Net Income | -18.39M | -18.92M | -18.1M | -43.76M | -27.76M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 138.59M | 142.81M | 142.27M | 114.61M | 93.16M |
| Total Liabilities | 24.94M | 33.51M | 41.46M | 39.06M | 40.73M |
| Total Equity | 113.65M | 109.3M | 100.81M | 75.55M | 52.43M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -19.14M | -16.05M | -5.39M | -18.48M | N/A |
| Investing | -270k | -95k | 4.95M | -175k | N/A |
| Financing | N/A | 22.18M | 19.58M | 13.41M | N/A |
| Market Cap | 22.13M |
| Price to Earnings Ratio | -0.62 |
| Price to Sales Ratio | 4.24 |
| Price to Cash Ratio | 0.62 |
| Price to Book Ratio | 0.33 |
| Dividend Yield | - |
| Shares Outstanding | 50.3M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.44 |
| 52 Week Low | 0.44 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Nicox SA Eur (CE) |
| Address |
drakkar 2 – bat d grasse, alpes-maritimes 06560 |
| Website | https://www.nicox.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
